April 30 (Reuters) - Danish drugmaker LEO Pharma said on Thursday it had agreed to buy U.S. drug developer Replay for $50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results